Multidisciplinary tumor boards are very important to most cancers therapy plans, bringing collectively clinicians from totally different specialties to information affected person therapy and enhance outcomes. Nonetheless, compiling the related knowledge for every case is time-consuming and requires contributions from a number of staff members. To optimize the method, researchers on the MU Faculty of Drugs partnered with Roche Diagnostics to judge a cloud-based product known as NAVIFY® Tumor Board that integrates all related medical knowledge for a tumor board right into a single digital dashboard accessible to everybody. Throughout a 16-month medical research of the dashboard, researchers discovered NAVIFY Tumor Board considerably decreased the period of time medical doctors and nurses throughout a number of specialties spent making ready for 227 tumor board conferences involving 1866 affected person instances.
“Along with saving time, the NAVIFY digital tumor board resolution resulted in much less variability in preparation time,” mentioned Richard Hammer, MD, professor of pathology on the MU Faculty of Drugs and vice chair of medical affairs within the Dept. of Pathology and Anatomical Sciences. “The enhancements have been sustained and have become extra important over time, lowering administrative burdens of assembly preparation.”
Hammer evaluated case preparation time throughout 4 phases: earlier than NAVIFY Tumor Board implementation, after handbook implementation, after partial digital medical document (EMR) integration and after a steady EMR integration section. The research discovered a 30% preparation time discount throughout three most cancers classes with full integration in comparison with pre-implementation. The largest time financial savings concerned the breast tumor board, the place nurse navigators decreased their preparation time by 69%.
“Establishments with devoted nurses making ready for instances will possible profit probably the most,” Hammer mentioned. “This dashboard permits quick access to medical knowledge, which can help optimum decision-making. As well as, it reduces prices for each sufferers and hospitals, which is presently below evaluation.”
Hammer’s staff can also be within the strategy of submitting knowledge on the impression of the NAVIFY medical determination help software program on case dialogue time throughout tumor board conferences. Future research will examine its impression on the standard of case discussions.
“As the primary reference website for NAVIFY Tumor Board within the U.S., we’re already internet hosting different institutional leaders to assist them implement this software program,” Hammer mentioned. “That is the wave of the long run, the place we’re utilizing digital medical determination help software program to boost how we look after sufferers, whereas bettering effectivity, standardizing the preparation of instances and making them obtainable to clinicians at any time.”
Along with Hammer, the research’s co-authors included MU Faculty of Drugs colleague Lincoln Sheets, MD, assistant analysis professor. Hammer acquired analysis funding, an honoraria and serves as an advisor for Roche.